Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma

NCT05079282 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

217

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed or Refractory T Cell Lymphoma

Interventions

DRUG: ONO-4685

Sponsor

Ono Pharmaceutical Co., Ltd.